Recordati Updates on Share Buyback Program

An announcement from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.

Recordati S.p.A. has announced an update on its share buyback program, which commenced on April 30, 2025. The program aims to purchase shares for stock option and performance share plans for the management of the Recordati Group. Between September 8 and September 12, 2025, the company purchased a total of 63,869 shares at a weighted average price of €54.0053 per share. As of September 12, 2025, Recordati holds 4,234,088 own shares, representing 2.025% of its share capital. This strategic move is expected to support the company’s incentive plans and potentially enhance shareholder value.

The most recent analyst rating on (IT:REC) stock is a Hold with a EUR57.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on the Italian Stock Exchange. Originating from a family-run pharmacy in Northern Italy, the company provides therapeutic options in general and specialist medicine, as well as for rare diseases. Recordati is involved in clinical development, production, marketing, and licensing of active ingredients and finished products, operating in about 150 countries across EMEA, Americas, and APAC regions with over 4,580 employees.

Average Trading Volume: 233,018

Technical Sentiment Signal: Strong Buy

Current Market Cap: €11.05B

See more data about REC stock on TipRanks’ Stock Analysis page.